Trial Profile
A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Gastroparesis; Otitis media; Pelvic inflammatory disorders; Sexually transmitted infections
- Focus Adverse reactions
- 19 Jun 2018 Status changed from recruiting to withdrawn prior to enrolment.
- 19 Jun 2018 Planned primary completion date changed from 1 Dec 2018 to 31 Dec 2017.
- 18 Dec 2015 New trial record